Brentuximab vedotin

From WikiMD.org
Jump to navigation Jump to search
Brentuximab vedotin
TermBrentuximab vedotin
Short definitionbrentuximab vedotin - (pronounced) (bren-TUK-sih-mab veh-DOH-tin) medicine used alone or with other medicines to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classic Hodgkin's lymphoma, or mycosis fungoides, and with other medicines to treat children aged 2 years and older used with certain medicines Types of classical Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


brentuximab vedotin - (pronounced) (bren-TUK-sih-mab veh-DOH-tin) medicine used alone or with other medicines to treat adults with certain types of cutaneous or systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma, classic Hodgkin's lymphoma, or mycosis fungoides, and with other medicines to treat children aged 2 years and older used with certain medicines Types of classical Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Brentuximab Vedotin contains a monoclonal antibody that attaches to a protein called CD30 found on some lymphoma cells. It also contains a cancer drug that can help kill cancer cells. Brentuximab vedotin is a type of antibody-drug conjugate. Also called Adcetris and SGN-35

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski